ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 04/20/2026 at 22:05, 15 days 9 hours ago

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Abivax informs shareholders about the Annual Ordinary and Extraordinary General Meeting on May 11, 2026, in Paris, providing access to preparatory documents

Shareholders Abivax General Meeting Clinical-stage Biotechnology Preparatory Documents
BRIEF

published on 04/17/2026 at 15:48, 18 days 16 hours ago

JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX

Voting Rights Abivax Threshold Crossing JP Morgan Indirect Ownership
BRIEF

published on 04/17/2026 at 15:48, 18 days 16 hours ago

JP Morgan Chase & Co. dépasse le seuil de 5% dans ABIVAX

Droits De Vote Franchissement De Seuil Abivax JP Morgan Détention Indirecte
PRESS RELEASE

published on 04/17/2026 at 15:43, 18 days 16 hours ago

Franchissement de seuil
JP Morgan Chase & Co. has declared crossing the 5% ownership threshold in Abivax on April 8, 2026, indirectly through controlled entities

Déclaration Franchissement De Seuil AMF Abivax JP Morgan Chase & Co.
BRIEF

published on 04/17/2026 at 10:42, 18 days 21 hours ago

JP Morgan Chase & Co. reduces its stake in ABIVAX

Euronext Paris Voting Rights Abivax Threshold Crossing JP Morgan
BRIEF

published on 04/17/2026 at 10:42, 18 days 21 hours ago

JP Morgan Chase & Co. réduit sa participation dans ABIVAX

Euronext Paris Droits De Vote Franchissement De Seuil Abivax JP Morgan
PRESS RELEASE

published on 04/17/2026 at 10:37, 18 days 21 hours ago

Franchissement de seuil
Déclaration de franchissement de seuil par JP Morgan Chase & Co. concernant ABIVAX sur Euronext Paris le 10 avril 2026

Euronext Paris Abivax JP Morgan Chase & Co. Déclaration De Franchissement Seuil
BRIEF

published on 04/08/2026 at 12:17, 27 days 19 hours ago

Abivax présente les résultats de l'essai ABTECT

Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Tolérance
BRIEF

published on 04/08/2026 at 12:17, 27 days 19 hours ago

Abivax presents the results of the ABTECT trial

Abivax Obefazimod Ulcerative Colitis Clinical Trial Tolérance
PRESS RELEASE

published on 04/08/2026 at 12:12, 27 days 19 hours ago

Abivax annonce la présentation des derniers résultats de l'essai ABTECT de 8 semaines avec des données de tolérance actualisées
Abivax annonce les derniers résultats de l'essai ABTECT de 8 semaines évaluant Obefazimod dans le traitement de la rectocolite hémorragique. Présentation des données de tolérance actualisées lors de la Semaine UEG à Berlin

Abivax Obefazimod Tolérance UEG Semi-hebdomadaires

Published on 05/06/2026 at 02:17, 5 hours 36 minutes ago

Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 5 hours 53 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 5 hours 53 minutes ago

Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 6 hours 23 minutes ago

Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 6 hours 33 minutes ago

Empress Grants Stock Options and Equity Incentives

View all ACCESSWIRE

Published on 05/06/2026 at 07:30, 22 minutes ago

BIKE24 off to a strong start in 2026 – 21.9% revenue growth and a significant improvement in adjusted EBITDA to EUR 1.8 million
Published on 05/06/2026 at 07:30, 22 minutes ago

Masterflex starts the 2026 financial year with stable revenue development and increasing profitability – guidance confirmed
Published on 05/06/2026 at 07:30, 23 minutes ago

Mutares has sold Peugeot Motocycles to its Management
Published on 05/06/2026 at 07:30, 23 minutes ago

ZEAL grows despite weak jackpot situation and further expands its product portfolio
Published on 05/06/2026 at 07:30, 23 minutes ago

Growth prospects improved: Infineon raises full-year guidance. AI boom strengthens further. Automotive order intake improves. Revised segment structure effective from the fourth quarter

View all EQS

Published on 05/05/2026 at 19:00, 12 hours 53 minutes ago

Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 12 hours 53 minutes ago

Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 13 hours 13 minutes ago

Share Buyback program
Published on 05/05/2026 at 18:40, 13 hours 13 minutes ago

Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 13 hours 49 minutes ago

Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026

View all LES ECHOS COMFI WIRE

News